Surgical Management of Hereditary Breast Cancer
The identification that breast cancer is hereditary was first described in the nineteenth century. With the identification of the BRCA1 and BRCA 2 breast/ovarian cancer susceptibility genes in the mid-1990s and the introduction of genetic testing, significant advancements have been made in tailoring...
Main Authors: | Elizabeth R. Berger, Mehra Golshan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/9/1371 |
Similar Items
-
Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition
by: Ismail Jatoi
Published: (2018-10-01) -
Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?
by: Roberta Zuntini, et al.
Published: (2021-05-01) -
Clinical Outcome of Hereditary Breast Cancer in the Lithuanian Population
by: Elsakov Pavel, et al.
Published: (2005-04-01) -
Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
by: Edenir Inêz Palmero, et al.
Published: (2020-04-01) -
Challenges and Considerations on Risk-Reducing Surgery in <i>BRCA1/2</i> Patients with Advanced Breast Cancer
by: Leonor Vasconcelos de Matos, et al.
Published: (2021-01-01)